Global Summit Chairman, Executive Director, King Abdullah International Medical Research Center, KSA
Ahmed Alaskar is a Consultant and a Professor, Adult Hematology & Stem Cell Transplantation at King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs. He is also the Executive Director, King Abdullah International Medical Research Center and the President of Saudi Society of Blood and Marrow Transplantation (SSBMT).
Prof. Alaskar gained his MBBS from King Saud University and completed medical trainings at University of British Columbia, Vancouver, Canada where he obtained both the Canadian and the American Boards of Internal Medicine and of Hematology and Stem Cells Transplantation.
He assumed numerous administrative tasks and positions since 2001. He was the Director, Inpatient Services at King Abdulaziz Medical City – Riyadh and the Program Director of the Saudi Board Preparatory Course for Internal Medicine. He led the Department of Oncology at its establishment stage in 2005/2006 while he continued to be the Head, Division of Adult Hematology & Hematopoietic Stem Cell Transplantation until March 2015. He was one of the founders of the Saudi Scientific Society of Blood and Marrow Transplantation in the Kingdom of Saudi Arabia and was elected twice to be the President of the society. He was then appointed as Deputy Executive Director, King Abdullah International Medical Research Center from May 2010 and became the Executive Director in September 2013 until present.
Prof. Alaskar has more than 100 publications and involved in numerous local and national committees and member of several International Societies.
Dr. Ahmed Alaskar
Global Summit Chairman,
Executive Director,
King Abdullah International Medical Research Center, KSA
Dr. Aiman Altamimi
Dr. Altamimi is an assistant professor of Computer Science and holds a master’s degree in Medical Education. His research interest spans the field of Information Retrieval (IR) specifically secondary assessors’ behavior, which is important in evaluating IR systems, and How to develop Computer Science Curricula for Health-Oriented students.
Dr. Aiman Altamimi
General Director, University Relations and Media Affairs, King Saud bin Abdulaziz University for Health Sciences, KSA
Dr. Abdelali Haoudi
“We are now witnessing the dawn of new era where we can no longer look at biomedical R&D centers separately from healthcare innovation centers and Biotechnology enterprises. The current COVID19 global pandemic has raised a serious alarm that the existing Biotech and Biopharma is still facing major challenges to rapidly and effectively cope with global health pandemics. Therefore, our proposed Riyadh Global Biotech Summit will bring together taught leaders in the field to push the boundaries of our existing thinking and practice and propose innovative models that will impact the country, the region and the rest of the world with direct impact on health and economy.“
Dr. Haoudi is currently leading the Strategy and Business Development and is also Managing Director of the Biotechnology Park at King Abdullah International Medical Research Center, at the Ministry of National Guard Health Affairs, and is also Distinguished Scholar at Harvard University/Boston Children’s Hospital.
Dr. Haoudi has held several senior positions in Research and Development and Innovation, including Founding Vice President for Research, Executive Director for Biomedical Research Institute and Chairman at National Research Fund at Qatar Foundation.
Dr. Haoudi served also as Research Professor of cancer and infectious diseases at the University of Virginia and Eastern Virginia Medical School and a fellow of the US National Institutes of Health. He has also held several other positions in elite research and education institutions including Visiting Professor at Harvard Medical School (USA) and a fellow at Institut Pasteur (France).
Dr. Haoudi was elected as a member of Hassan II Academy for Science and Technology in 2006 and graduated from University Paris XI and Paris VI, France in 1996 with a doctoral degree in cellular and molecular genetics and received executive education from Harvard Business School in Corporate Management and Strategy and received multiple awards including Fogarty International Award and has published numerous peer reviewed international research publications and served as Founder and Editor-In-Chief for the Journal Biomed Research International and is a member of the international advisory board for the Lancet Oncology and member of the Scientific Advisory Board of the MASciR Foundation for Science, Research and Innovation.
Dr. Abdelali Haoudi
Global Summit Vice Chairman,
Head, R&D Strategy and Business Development,
Managing Director, Medical Biotechnology Park,
King Abdullah International Medical Research Center, KSA
Dr. Raed H. AlHazme
Raed H. AlHazme, PhD, is the Executive Director of the IT Department at the Ministry of National Guard Health Affairs (MNGHA),KSA.
and the IDC CIO of the Year 2021.
The scope of the IT department at MNGHA covers 2 medical cities, 3 hospitals and 72 primary healthcare centers distributed across the Kingdom of Saudi Arabia.
Dr. AlHazme has been involved in the management of IT departments in different environments for more than 15 years.
Led by Dr. AlHazme, MNGHA’s digital transformation process has progressed to a high-level of digital maturity.
As per the Healthcare Information and Management Systems Society (HIMSS), MNGHA is the only healthcare organization in the world that has reached quadruple Stage 7 (highest level) on HIMSS’s digital maturity models.
Furthermore, MNGHA King Abdulaziz Medical City has been selected in 2021 as one of the 250 top Smart Hospitals in the World based on the renowned Newsweek ranking.
Academically, is an adjunct assistant professor in the health informatics department at King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia, and in the biomedical informatics department at Nova Southeastern University, FL, USA. Dr. AlHazme’s research activities are focused on digital transformation, health informatics and data science,
which involved publishing a number of scientific literatures and registering four patents at the United States Patent and Trademark Office.
Dr. Raed H. AlHazme
Executive Director, IT Department,
Ministry of National Guard Health Affairs, KSA
Dr. Majed Al Jeraisy
With a Bachelor degree of Science in pharmacy from King Saud University, Riyadh 1991, a Master of Science degree in Clinical Pharmacy KSU, 1996. Further on completed Doctor of Pharmacy from university of Tennessee, USA 1999. And in 2009, completed Master of Science in medical Education, KSAU-HS, Riyadh.
Currently, I am an Associated Professor, Collage of pharmacy, King Saud Bin Abdulaziz University for health science as well as pediatric Clinical Pharmacy consultant, King Abdullah Specialized hospital.
I am appointed Director of Clinical Trial Services, in addition to Chairman of Research Office, King Abdullah International Medical research Center.
I participated in a number of workshops and courses including American College of Clinical Pharmacy, Master class in Effective Leadership and Anti- Thrombosis Certificate program.
I am a reviewer of some local and international peer reviewed journals, also authored and co-authored numerous and relevant papers in the field of Pediatrics, Pharmacotherapy, General Medicine, Biochemistry, Pharmacology and Toxicology that were published in reputable Journals.
Dr. Majed Al Jeraisy
Chairman, Research Office, Director, Clinical Trial Services, King Abdullah International Medical Research Center, KSA
Dr. Majed Al Ghoribi
Dr. Majed Alghoribi is currently Chairman of the Infectious Diseases Research Department and Associate Research Scientist at King Abdullah International Medical Research Center (KAIMRC). Member of COVID-19 National Research Committee in Saudi Arabia; Member of National Public Health Laboratory Committee in Saudi Arabia; Member of Food Safety and Risk Assessment Advisory Committee at Saudi Food and Drug Administration; Member of National Antimicrobial resistance program In Saudi Arabia. He has been involved in postgraduate teaching and training in different national and international universities.
Dr. Alghoribi completed his Bachelor of Science in Microbiology at Umm Al-Qura University, Saudi Arabia, Master degree in Molecular and Medical Microbiology at the University of Manchester, UK, and PhD in Infection, immunity, inflammation and repair at the school of Medicine at The University of Manchester. In addition, Dr. Alghoribi obtained another master degree in Leadership and Management for Healthcare Practice at the University of Salford, UK. He continued his postdoctoral fellowship at Public Health England, London, UK working at the Antimicrobial Resistance and Healthcare-Associated Infection (AMRHAI) reference unit with Prof. Neil Woodford group. Dr. Alghoribi established the National Guard Health Affairs (NGHA) whole-genome sequencing-based surveillance of clinically important pathogens, including AMR, MERS-CoV, and SARS-CoV-2. He has a wide range of research activities and publications in peer-reviewed journals in the field of microbial genomics and antimicrobial resistance.
Dr. Majed Al Ghoribi
Chairman, Infectious Diseases Research Department,
King Abdullah International Medical Research Center, KSA
Dr. Manal Alaamery
Dr. Manal Alaamery, is currently the Chairman of Innovation and Entrepreneurship Department (IED) and Head of the Developmental Medicine Department (DMD) at the King Abdullah International Medical Research Center (KAIMRC), KSA, at the Ministry of National Guard-Health Affairs (MNGHA). She is also the director of the satellite lab for the National Saudi Genome Program at KAIMRC, and a Principal Investigator at the Center of Excellence for Biomedicine (CEBM) at King Abdulaziz City for Science and Technology (KACST) and Brigham Woman’s Hospital (BWH) in association with Harvard Medical School. Formerly, she was an instructor at the Harvard Medical School and Children’s Hospital Boston.
As the chairman of IED, she is responsible for the ongoing Innovation activities at KAIMRC/KSAU-HS and the MNGHA. The IED was established to serve the Kingdom’s vision 2030 and further enhance its resources and economic stability. Dr. Alaamery provides leadership in the identification and KAIMRC-wide adoption of innovation metrics to optimize KAIMRC’s research and innovation portfolio. Some of the IED activities include creating Innovation and entrepreneurship programs specifications, documentation, and materials, registering patents, copyrights, and trademarks at patent offices around the world. Her main focus in the research development stages and played an instrumental role in the advancement of basic research to the biotech industry.
As the Head of DMD, Dr. Alaamery’s research investigates the causes of different genetic disorders such as understanding the genetic causes of non-syndromic congenital heart defect in the Saudi population with the goal of identifying novel genes and therapeutic targets for rare disorders. In addition, with the collaborators from BHW and KACST, she and her team are studying the role of sphingolipid metabolism in neurodegeneration to identify candidate targets for therapeutic intervention for different neurodegenerative disorders such as multiple sclerosis (MS). Furthermore, during the COVD-19 pandemic and given the lack of knowledge in the genetic basis of SARS-CoV-2 infection pathogenesis in Saudi, Dr. Alaamery got involved in a national/ international project (KAIMRC-KACST) focused on identifying human genetic determinants of SARS-CoV-2 susceptibility, severity and outcome in the Saudi population.
Dr. Alaamery received her clinical and postgraduate training at Harvard Medical School Genetics Program. She completed her clinical training at the Laboratory of Molecular Medicine (LMM) at Harvard focused on the areas of Hypertrophic and Dilated Cardiomyopathies, Neurological disorders, Muscular disorders, Hearing loss, Noonan spectrum, Pharmacogenetics. Dr. Alaamery also holds a Doctoral (Ph.D.) degree in Molecular Genetics/Biology from Boston College and a Master of Science degree in Clinical Microbiology from Thomas Jefferson University.
During Dr. Alaamery’s work and career, she has established herself as a research leader, and published in prestigious peer-reviewed scientific journals as well as patenting a number of novel ideas. Dr. Alaamery also taught several courses, led many initiatives and held several committee positions. In addition, Dr. Alaamery is the recipient of several awards including the Dubai Harvard Foundation for Medical Research Award, Harvard Partners in Excellence Award for team work.
Dr. Manal Alaamery
Head, Developmental Medicine,
Chairman, Innovation and Entrepreneurship,
King Abdullah International Medical Research Center, KSA
Dr. Lamya Alomair
Dr. Lamya is recognized in Saudi Arabia as an influencer and innovator in the field of technology. She has an extensive list of accomplishments, participating in numerous national technological projects, collaborating with different healthcare institutions and professionals globally. These information health system projects have had a positive impact on improving healthcare delivery, assisting healthcare professionals to make more efficient and effective decisions and to embrace trending innovations in the field, enabling successful digital transformations in Saudi Arabia.
Dr. Lamya Alomair is currently the Head of AI and Bioinformatics at King Abdullah International Medical Research Center (KAIMRC), and an affiliated faculty member at George Mason University, USA. Her work was featured in several international media, including first edition by MIT Technology Review, In 2022, with her deep knowledge analytics she was picked as one of the "Top 30 Leading Arab Experts in AI 2022".
Dr. Alomair earned her PhD in Bioinformatics and Computational Biology from GMU, USA.
Dr. Alomair has been examining the rapidly evolving field of AI, exploring its current and potential applications in healthcare sectors. She is organizing many symposiums and workshops in the field of AI. She is an active supporter and enabler in the fields of both AI and Big Data. She regularly promotes AI & Bioinformatics as a guest speaker.
Dr. Alomair serves on several national committees to build AI and Bioinformatics national strategy development. She utilizes her excellent communication skills and actively involving in building various strategies for collaboration nationally and internationally. She also offers her expertise to healthcare projects and research consultancy to promote the advancements and implementations.
Dr. Lamya Alomair
Head, AI and Bioinformatics,
King Abdullah International Medical Research Center, KSA
Dr. Bader Alahmari
Dr. Bader Alahmari obtained MBBS from King Khalid University in 2005 and finished his Residency in Internal Medicine from King Abdulaziz Medical City- Riyadh,KSA, and obtained the Saudi Board in Internal Medicine in 2010. He then carried on to complete his clinical fellowship in Hematology/ Oncology in 2016 as well as the fellowship in Bone Marrow Transplant from Washington University School of Medicine, St. Louis, Missouri, USA in 2017. He also obtained Master of Science in Clinical Investigation, Translation Medicine Track from the same institution in 2017. Currently, he is a consultant in Stem Cell Transplantation and Cellular Therapy Division, Department of Oncology, Ministry of National Guard Health Affairs-Riyadh. He has multiple publications focused in the development of novel therapeutic targets for graft versus host disease (GVHD) in experemental murine GVHD model. His current research work focuses in the development of cellular theapy for cancer management.
Dr. Bader Alahmari
Director, Hematology Fellowship Program,
Consultant, Adult Stem Cell Transplant and Cellular Therapy,
Department of Oncology, King Abdulaziz Medical City, KSA
Dr. Majid Alfadhel
Dr. Alfadhel is currently Deputy Executive Director of King Abdullah International Medical Research Center (KAIMRC), Chairman of Genetics and Precision Medicine department at King Abdulaziz Medical City, Riyadh, Saudi Arabia, Director of Medical Genomic lab at King Abdullah International Medical Research Center (KAIMRC), and Professor of Pediatrics and Genetics at King Saud bin Abdulaziz University for Health Sciences (KSAU-HS).
Additionally, he is founder and editor in chief of Journal of Biochemical and Clinical Genetics, Editorial board member of International Journal of Health Sciences, Editorial board member of the Journal of Nature and Science of Medicine (JNSM), Editorial board member of BMC Pediatrics, Editorial board member of Frontier in Pediatric Neurology, Authors of 3 books and one chapter in a book and editorial board member of several international journals. Has more than 155 publication in high impact factor journals and more than 100 abstracts. He is supervisor and teachers for plenty of fellows, residents and medical students.
He was successful in contribution in discovery of 50 novel genes specifically for disorders involving the brain.
Prof. Alfadhel’s foresight and passion for innovation, earned him an award for inventing a new application in the Apple store and Goggle play for the treatment of inborn errors of metabolism.
Prof. Alfadhel received his bachelor degree in general medicine and surgery from King Saud University in Riyadh. He obtained his pediatric residency from King Abdulaziz Medical City in Riyadh and received the Pediatric Saudi Board certificate followed by Pediatric Arab Board certificate and the Canadian Board in Biochemical Genetics. In addition, he carries a Neurogenetics fellowship certificate and Master of Health Science (MHSc) in epidemiology. He is also a Chair at the Newborn Screening Program of King Abdulaziz Medical City, member of advisory board of national Newborn Screening Program and member of Middle East Hyperammonemia and UCDs Scientific Group (MHUSG). Prof. Alfadhel’s foresight and passion for innovation, earned him an award for inventing a new application in the Apple store for the treatment of inborn errors of metabolism. He has published several research papers in the field of Genetics disorders, and participated in several conferences and symposia. Prof. Alfadhel’s current research interest is focused on studying clinical genetic disorders and inborn errors of metabolism epidemiology, diagnosis and treatment, novel gene discoveries in this area, gene therapies and prenatal genetics.
Dr. Majid Alfadhel
Deputy Executive Director, King Abdullah International Medical Research Center, Chairman, Genetics and Precision Medicine Department, King Abdulaziz Medical City, KSA
Dr. Bader Aldebasi
Deputy Head of Research Training & Development Section, KAIMRC, Riyadh
PhD in Medical Imaging from University of Nottingham, England, UK, 2014
Masters in Medical Imaging from University of Leeds, England, UK, 2005
BSc in Applied Medical Sciences in the field of Radiological Sciences, from Weber State University, USA, 2001
Assistant Professor of Radiology, College of Applied Medical Science, KSAU-HS
Deputy Head of Research Training & Development Section, KAIMRC, Riyadh
Associate Research Scientist at KAIMRC, Riyadh
Dr. Bader Aldebasi
Deputy Head, Research Training & Development Section, King Abdullah International Medical Research Center, KSA
Dr. Dunia Jawdat
Prof. Jawdat is the Chairman of the department of Cellular Therapy Services, which includes the Saudi Stem Cell Donor Registry (SSCDR), Cord Blood Bank, Stem Cell Laboratory and Cellular Therapy Laboratory at King Abdullah International Medical Research Center. She is a Senior Research Scientist and a Consultant Clinical Scientist in the field of Immunology certified by the American Board of Medical Laboratory Immunology.
Prof. Jawdat is a Professor of Immunology in the College of Medicine, and the Chair of the Department of Basic Sciences at the Female Branch of the College of Sciences and Health Profession at King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS).
Prof. Jawdat is an active member of numerous professional societies including the International Society for Cellular Therapy (ISCT), the American Society of Histocompatibility and Immunogenetics (ASHI), European Society of Blood and Marrow Transplantation (EMBT), and the Saudi Society of Blood and Marrow Transplantation (SSBMT). She is serving as the Vice president of the Arabian Society for Histocompatibility and Immunogenomics (ARSHI) and a board member of the World Marrow Donor Association (WMDA) and Chair of Supporting Global Development. Furthermore, Dr. Jawdat is a WMDA Quality/ Accreditation Experienced Reviewer, and Foundation for the Accreditation of Cellular Therapy (FACT) quality standard reviewer and inspector.
Dr. Dunia Jawdat
Chairman, Department of Cellular Therapy Services,
King Abdullah International Medical Research Center, KSA
